ArticleAnnals of medicine2025
Predicting six-month mortality in adult hemophagocytic lymphohistiocytosis with machine learning: a prognostic approach utilizing laboratory data.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early Differential Diagnosis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Children: A Clinical Prediction Model Based on 106 Patients.Pathogens (Basel, Switzerland) · 2026Article
- Association between first-year axial elongation and 10-year myopia progression in children wearing orthokeratology lenses: a ten-year longitudinal study.Frontiers in cell and developmental biology · 2026Article
- Establishing and validating a predictive model for long-term control outcomes following orthokeratology lenses wear: a five-year cohort study.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHemophagocytic lymphohistiocytosis (HLH) is associated with high mortality rates. This study was conducted to develop and validate a predictive model for adult HLH patients at high risk of six months mortality using machine learning (ML) algorithms.
methodsThe study utilized univariate analysis and LASSO regression, incorporating eleven ML algorithms, to perform a comprehensive analysis of both admission and discharge variables. Model performance was assessed using metrics such as AUC, F1 score, Kaplan Meier (KM) curves, calibration curves and decision curve analysis (DCA).
resultsA total of 136 patients meeting the HLH-2004 criteria were included in this study. Among them, 59 patients received chemotherapy or other cytotoxic drugs, while the remaining 77 patients underwent symptomatic treatment. The median age was 52 years among nonsurvivors and 48 years among survivors, with 47 (42.6%) males in the nonsurvivor group and 31 (47.6%) in the survivor group. Age and nine discharge variables were identified as the most significant features for model construction. Random forest (RF) algorithm demonstrated superior predictive capabilities, achieving an AUC of 1.00, accuracy of 0.98 and F1 score of 0.98 in the training cohort, and an AUC of 0.89, accuracy of 0.85 and F1 score of 0.85 in the validation cohort. The top five predictors were all discharge variables (ferritin, white blood cell (WBC), albumin (ALB), platelet (PLT) and direct bilirubin (DB)).
conclusionThe predictive model developed in this study provides a valuable tool for clinicians to early identify high-risk HLH patients, thereby enabling more targeted and effective interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.